Vectibix

Description

Vectibix is ​​intended for the treatment of metastatic colorectal cancer (mCRC) in adult patients with wild-type RAS genes in the tumor:

– as first line therapy in combination with regimens containing fluorouracil, calcium folinate and oxaliplatin (FOLFOX) or fluorouracil, calcium folinate and irinotecan (FOLFIRI);

– as second-line therapy in combination with a regimen containing fluorouracil, calcium folinate and irinotecan (FOLFIRI) in patients who have previously received first-line fluoropyrimidine-based chemotherapy (excluding irinotecan);

– as monotherapy when chemotherapy regimens based on fluoropyrimidine, oxaliplatin and irinotecan are ineffective.

Active ingredient: panitumumab

Prescription medicine

Storage temperature 2-8 degrees